Long non-coding RNAs: The novel diagnostic biomarkers for leukemia

Environ Toxicol Pharmacol. 2017 Oct:55:81-86. doi: 10.1016/j.etap.2017.08.014. Epub 2017 Aug 18.

Abstract

Long non-coding RNAs (LncRNAs) are a category of non-coding RNAs (ncRNAs) with a length of 200nt-100kb lacking a significant open reading frame. The study of lncRNAs is a newly established field, due in part to their capability to act as the novel biomarkers in disease. A growing body of research shows that lncRNAs may not only useful as biomarkers for the diagnosis and clinical typing and prognosis of cancers, but also as potential targets for novel therapies. Differential expression of lncRNAs has been found in leukemia in the last two years, however, the majority of the lncRNAs described here are transcripts of unknown function and their role in leukemogenesis is still unclear. Here, we summarize the lncRNAs associated with leukemia in order to find a potential classification tool for leukemia, and a new field of research is being explored.

Keywords: Biomarkers; Classification tool; Leukemia; Long non-coding RNA.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Gene Expression Regulation, Neoplastic
  • Gene Regulatory Networks
  • Humans
  • Leukemia / diagnosis*
  • Leukemia / genetics
  • Prognosis
  • RNA, Long Noncoding / genetics*

Substances

  • Biomarkers, Tumor
  • RNA, Long Noncoding